2016 NEI/FDA Endpoints Workshops

Nov 09, 2016 Bethesda, Maryland

AMD and inherited retinal diseases ― recording

EndpointsLOGO     

The Workshop was held live and via webcast on November 9, 2016.  

The recording was available for purchase through June 30, 2017 and it will be accessible through June 30, 2018.

Workshop summary
Age-related macular degeneration (AMD) and inherited retinal diseases, such as geographic atrophy and retinitis pigmentosa, are leading causes of vision loss in the U.S. This workshop included the newest clinical data on inherited retinal diseases and future clinical trial designs that are aimed at developing therapies to stem vision loss.

This one-day public workshop reviewed clinical trial design considerations for AMD and inherited retinal diseases in order to develop strategies for:

  • improved trial design and endpoints based on current evidence
  • approaches to classifying and stratifying the patient population
  • clinically meaningful surrogate or interim endpoints
  • potentially impactful gaps for research funding


 Co-sponsored by: 
FoundationFightingBlindness

Advertisement
Harrington tower ad